ARCHIVES

Two Reports Offer Definitions, Plans For Comparative Effectiveness Research

This article is from The Cancer Letter archive.

Vol. 35 No. 26 | July 3, 2009

Download PDF Visit The Full Archive

Related Articles

FDA Likely To Change Procedures For Patient Interaction, Official Says

November 10, 1995

FDA Simplifies Reporting Of Adverse Events

June 18, 1993

In Brief: Three Patients Evaluated For Gene Therapy; Revised Program Instructions Available

November 30, 1990

Aflibercept Improves Overall Survival In Second-Line Colorectal Cancer Setting

April 29, 2011

Market Forces Changing Health Care System, Oncologists Told

June 2, 1995

COG’s Peter Adamson Has A Conversation With The Cancer Letter

March 15, 2013